New Research from The Fuchsia Tent Shows Making Midlife Women Visible in Employer Health Data Could Save U.S. Companies $26.6B
MWN-AI** Summary
New research from The Fuchsia Tent highlights that recognizing midlife women's health needs—specifically around menopause—in employer health data could lead to significant savings for U.S. companies, estimated at $26.6 billion annually. This comprehensive report synthesizes findings from over 25 peer-reviewed studies, revealing a systemic oversight in women's health representation within workplace benefit systems.
Despite all women aged 45 to 64 experiencing some degree of menopausal transition, only 14.7% have any corresponding medical records, leading to misdiagnosis and underdiagnosis of conditions like anxiety and insomnia that are related to menopause. This oversight burdens employers with additional costs as symptomatic women are likely to face a 10% earnings penalty post-diagnosis, further highlighting the need for better healthcare integration.
The report identifies three critical areas contributing to this financial burden: a "Benefits Gap," where menopause-related needs are unseen in claims data; awareness campaigns that fail to create lasting behavioral changes; and barriers to accessing necessary hormone replacement therapies, which have drastically declined in usage. Only a mere 6.8% of medical residents receive training in menopause care.
To address these challenges, The Fuchsia Tent introduces The 3H Framework™, which encourages employers to conduct benefits audits to identify existing support, train managers in empathetic leadership, and remove barriers to access effective treatments. The majority of suggested recommendations involve optimizing currently available resources rather than incurring new costs.
Looking ahead, The Fuchsia Tent, alongside the Society for Women’s Health Research, has initiated a nationwide study titled "Menopause at Work: From Echo Chamber to Mainstream Practice" to gather insights from various stakeholders. The outcomes will aim to further bridge gaps in support for working women navigating menopause and drive systemic change in workplace wellness practices.
MWN-AI** Analysis
The recent research from The Fuchsia Tent presents a compelling opportunity for U.S. companies to enhance their health benefits for midlife women, potentially reaping savings of $26.6 billion annually. This revelation is critical not only for ethical and equality considerations but as a strategic business investment.
Midlife women, who represent a significant segment of the workforce, often face health challenges associated with menopause that remain inadequately addressed in employer health data systems. The Fuchsia Tent's findings suggest that a staggering 85.3% of women aged 45-64 lack diagnostic evidence of menopausal symptoms in their medical records. This not only leads to misdiagnosis and under-treatment but ultimately results in economic losses from decreased productivity and higher healthcare costs.
For businesses, the existing frameworks in health benefits—such as Employee Assistance Programs (EAPs) and telehealth services—can be reformulated to directly address menopausal health. By adopting The 3H Framework™, companies can perform benefits audits to illuminate gaps in communication and resource utilization, ensuring that female employees receive the support they need. By integrating menopause-related health information into existing programs and enhancing manager training, companies can foster a more supportive environment, leading to improved employee morale and productivity.
Investors should pay heed to employers that proactively implement these strategies, as they may enhance workforce stability and reduce costs. With the projected financial implications of the “Menopause Penalty,” organizations prioritizing comprehensive midlife women's health initiatives will likely find themselves at a competitive advantage.
In summary, organizations should not view menopause as a niche issue but as a critical component of their overall health strategy—one that promises significant cost savings and improved employee outcomes across the board. Engaging with this research could help companies not only meet current health needs but also position them more favorably in the market.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
A report based on 25+ peer-reviewed studies finds most employers already have the resources to support menopause at work. The 3H Framework™ connects the dots.
SALEM, Mass., March 3, 2026 /PRNewswire/ -- In the month dedicated to making women's contributions visible, a new research report by The Fuchsia Tent reveals that midlife women's health is systematically invisible in the employer benefits, data, and care systems designed to support them. Menopause is as certain as death and taxes for anyone who lives long enough, yet only 14.7% of women ages 45 to 64 have any evidence of it in their medical record despite 100% of that population being in some stage of the menopausal transition. Symptoms like anxiety, insomnia, joint pain, and cognitive changes are captured in ICD-10 coding as standalone conditions and never linked to menopause, leading to widespread mis- and underdiagnosis that costs U.S. employers an estimated $26.6 billion annually.
Why it matters: Most employers already offer health and well-being benefits that cover symptoms driven by fluctuating hormones, including medical plans, EAPs, mental health services, telehealth, and wellness programs. But because of poor coding and fragmented communication, these resources are rarely understood as relevant to the menopausal transition. Even when appropriate support exists, midlife women fail to recognize, access, or utilize it, and employers cannot measure a need they cannot see in their own data.
The financial picture for women is even more dire. Landmark 2025 research known as "The Menopause Penalty" found that symptomatic women experience a 10% earnings reduction within four years of diagnosis. "A penalty tied to biology would be eradicated with better structural support in healthcare and organizations, which benefits all employees, not just midlife women," writes report author Kacy Fleming, MA.
The good news: the majority of the report's recommendations do not require new budget lines or standalone vendor contracts.
What the research found: The report, Menopause at Work: Why Integration Beats Innovation, traces how costs compound across three interconnected pain points. The Benefits Gap: claims data cannot surface menopause and benefits communications do not name it. The Menopause Awareness / Training Trap: awareness campaigns and menopause-specific manager training produce no sustained behavioral change while potentially increasing stigma for the women they are designed to help. The Formulary Wall: treatment pathways are blocked by undertrained providers and formulary barriers that have driven HRT utilization from 26.9% down to 4.7% over two decades. Only 6.8% of medical residents are trained in menopause care, and 75% of women who seek help do not receive treatment.
The framework: The report introduces The 3H Framework™ to address all three pain points through systems employers already have. Healthcare starts with a benefits audit to identify existing resources and communicate them in language that connects them to the menopausal transition. Help builds universal leadership conversation capabilities that equip managers to support employees through a range of complex health and life situations, benefiting all employees rather than singling out one group. HRT and FDA-Approved Therapy Access removes formulary barriers keeping proven treatments out of reach.
What's next: To move from synthesis to primary evidence, The Fuchsia Tent and the Society for Women's Health Research have partnered on a national study titled "Menopause at Work: From Echo Chamber to Mainstream Practice," combining a multi-stakeholder survey with regional roundtables in four U.S. cities to capture perspectives from working women, employers, clinicians, and decision-makers, including voices typically absent from the conversation. Results are expected later this year.
Download the full report, Menopause at Work: Why Integration Beats Innovation at The Fuchsia Tent website.
About The Fuchsia Tent
The Fuchsia Tent is a workplace menopause strategy firm founded by Kacy Fleming, MA, an organizational psychologist, former Head of Global Well-Being at Takeda Pharmaceuticals, TEDx speaker, LinkedIn Top Voice, and three-time Business Group on Health Award recipient. Learn more at thefuchsiatent.com.
Contact:
Kacy Fleming, MA | Founder and CEO, The Fuchsia Tent
Kacy@thefuchsiatent.com | thefuchsiatent.com | +1 (310) 980-7402
SOURCE The Fuchsia Tent
FAQ**
How does Douglas Emmett Inc. DEI plan to implement the recommendations from The Fuchsia Tent's report to improve health data visibility for midlife women and potentially save on healthcare costs?
What strategies is Douglas Emmett Inc. DEI considering to overcome the barriers outlined in The Fuchsia Tent's report regarding the underutilization of menopause-related health benefits?
In the context of the Framework™ from The Fuchsia Tent's research, how might Douglas Emmett Inc. DEI enhance manager training to better support midlife women in the workplace?
How does Douglas Emmett Inc. DEI intend to participate in the upcoming national study on menopause at work to ensure that the voices of midlife women are reflected in employer health data?
**MWN-AI FAQ is based on asking OpenAI questions about Douglas Emmett Inc. (NYSE: DEI).
NASDAQ: DEI
DEI Trading
1.51% G/L:
$10.095 Last:
935,981 Volume:
$10.05 Open:
